Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Robert Lanza currently holds 206,509 shares of ADVANCED CELL TECHNOLOGY, INC. (ACTC), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Robert Lanza has been a net seller of ACTC stock. They have purchased $0 and sold $3.9M worth of shares.
Robert Lanza's most recent insider trade was on Feb 10, 2016, when they sold 231,509 shares at $8.50 per share.
Robert Lanza serves as Executive at ADVANCED CELL TECHNOLOGY, INC. (ACTC). They have executed 109 insider transactions totaling $3.9M over their tenure at the company.
Robert Lanza holds the position of Executive at ADVANCED CELL TECHNOLOGY, INC., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Robert Lanza has shown a selling trading pattern, with $0 in total purchases and $3.9M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Robert Lanza was on Feb 10, 2016, when they sold $2.0M worth of OCAT shares. This transaction involved 231,509 shares at $8.50 per share.
Robert Lanza currently owns 206,509 shares of ADVANCED CELL TECHNOLOGY, INC. (ACTC), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Robert Lanza's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Robert Lanza has 109 Form 4 filings on record as an insider at ADVANCED CELL TECHNOLOGY, INC..
Set alerts for Robert Lanza and 40,000+ other insiders.